ArticleCommunications biology2026
Structural insights into ubiquitin recognition by USP15 revealed through a covalent activity-based probe.
Article in Communications biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
Ubiquitin-specific protease 15 (USP15) catalyzes deubiquitination of multiple substrates involved in immune responses and cancer through diverse biological processes. However, its ubiquitin recognition and conformational transition mechanisms remain poorly understood. Here, we report the 2.3 Å crystal structure of the USP15 catalytic domain covalently bound to ubiquitin-propargylamine. This structure reveals that ubiquitin binding induces a conformational switch from an inactive-closed to an active-open state, driven by realignment of the catalytic triad and a hinge-like outward swing of the fingers subdomain. Importantly, we characterize two conserved structural features-an α8 helix and an α3-α4 loop-that are essential for maintaining the functional architecture of USP15 for ubiquitin engagement. Deletion of α8 destabilizes USP15 and abrogates its catalytic activity, while cancer-associated mutation P331S destabilizes the α3-α4 loop, weakens ubiquitin binding, and reduces catalytic efficiency. These previously less-characterized structural elements are critical for the enzymatic activity and structural integrity of USP15 and its paralogues, providing potential targets for selective inhibition of deubiquitinases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.